# CYTOCHROME P-450 GENES AND CHEMICAL CARCINOGENESIS

> **NIH NIH R01** · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 1991 · $185,970

## Abstract

The microsomal monooxygenase system, composed of the
cytochrome P-450s as the terminal oxidase, play a central role in
the metabolism of thousands of compounds including drugs,
xenobiotics and carcinogens.  The capacity of this system to
handle such a diverse array of compounds reflects both the large
number of distinct P-450s as well as the broad and overlapping
substrate selectivity.  These enzymes usually provide a defense
against undesirable chemicals that gain access to the cell.
However, certain forms are also capable metabolizing compounds
such as polycyclic aromatic hydrocarbons to highly reactive
intermediates that are capable of initiating a carcinogenic event.
Many of the different forms are regulated differentially according
age, tissue, inheritance and their ability to be induced in response
to different types of agents.  Therefore, variations in the
expression of different P-450s depending on factors such as age,
the level of induction following exposure to certain agents, or the
genetic events that contribute to heritable differences, can alter
the balance between the formation of toxic and non-toxic
products.

Differences in the expression of the P-450s can most be likely
attributed to transcriptional or post transcriptional events.  The
critical aspects of the process are the trans acting factors that
interact with cis acting regulatory sites in a manner which
modulates the expression of the various genes.  To understand the
molecular events that control the expression of the different P-
450s, we have developed cDNA and genomic clones to a number of
differentially regulated rabbit P-450s.  Clones have been
developed to rabbit P-450 4 and P-450 6.  Both of these P-450s
are inducible by polycyclic aromatic hydrocarbons and are
regulated differentially with respect to age and tissue.  We have
also identified cDNA and genomic clones to rabbit P-450 1, which
is expressed constitutively but reflects heritable differences
governing the amount of P-450 1 that is expressed in various
inbred rabbits and genetic crosses.  In addition, a cDNA clone that
encodes rifampicin inducible P-450 3c has also been identified.
Molecular approaches will be pursued to determine if cis and trans
acting factors can be identified that contribute to the differential
expression of the P-450 genes.  The employment of nuclear
extracts will be used in DNA footprint and in vitro transcription
analysis to determine the potential role of negative and positive
regulators of transcription in response to induction, tissue
specificity and temporal control.  In addition, experiments will be
outlined to determine the events that underlie the heritable
differences responsible for the regulation of P-450 1.  Combined,
we anticipate that a clear understanding of the regulatory events
as they relate to tissue specificity, age, inducibility and
inheritance of the different P-450 genes will evolve from these
studies.

## Key facts

- **NIH application ID:** 3174863
- **Project number:** 5R01CA037139-08
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN DIEGO
- **SAM.gov UEI:** UYTTZT6G9DT1
- **Principal Investigator:** Robert H Tukey
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 1991
- **Award amount:** $185,970
- **Award type:** 5
- **Project period:** 1984-04-01 → 1992-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/3174863

## Citation

> US National Institutes of Health, RePORTER application 3174863, CYTOCHROME P-450 GENES AND CHEMICAL CARCINOGENESIS (5R01CA037139-08). Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/grant/nih/3174863. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
